Reaction
Metastases To Pancreas reporting signals
As of the last recalculation, Metastases To Pancreas appears in 438 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is OCTREOTIDE ACETATE (PRR 91.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Octreotide Acetate | 52 | 91.4 | 91.6 |
| Everolimus Tablets | 16 | 47.0 | 47.1 |
| Pazopanib Hydrochloride | 23 | 42.6 | 42.6 |
| Sorafenib | 16 | 38.0 | 38.0 |
| Everolimus | 36 | 36.5 | 36.6 |
| Alpelisib | 6 | 33.2 | 33.2 |
| Cabozantinib | 30 | 31.8 | 31.8 |
| Pegaspargase | 8 | 31.6 | 31.6 |
| Gefitinib | 4 | 21.2 | 21.3 |
| Dabrafenib | 9 | 20.7 | 20.7 |
| Irinotecan Hydrochloride | 5 | 18.7 | 18.7 |
| Durvalumab | 7 | 16.6 | 16.6 |